20/20 Onsite

20/20 Onsite is a healthcare company in United States, founded in 2014. It has raised $8.0M across 4 rounds, most recently an $8.0M Growth Equity in May 2021.

Point-of-need ophthalmic clinical trial solutions

Employees
11–50
Founded
2014
Business Model
B2B
Total Funding
$8.0M
Last Round
$8.0M Growth EquityMay 2021
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 1 investor for this company. The full record is or through the API.

About

20/20 Onsite is a specialty clinical research organization providing end-to-end ophthalmic assessment services for sponsors and CROs conducting clinical trials with ocular endpoints. The company operates a nationwide fleet of point-of-need mobile ophthalmic units, enabling decentralized trial participation by bringing eye exams directly to patients rather than requiring them to travel to traditional clinical sites. With over 100,000 eye exams performed and 45+ clinical trials supported, 20/20 Onsite delivers single-call accountability for ocular endpoints across Phase 1 through Phase 3 studies, powered by a network of licensed optometrists.

Summary

It lists 11–50 employees. It has raised $8.0M in total across 4 rounds, most recently a $8.0M Growth Equity round in May 2021. Investors include Morningside Group.

Tech & App Stack

8 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityMay 2021
$8.0M

Sign up to see all 4 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

20/20 Onsite on Indexed.vc
<a href="https://indexed.vc/companies/20-20-onsite"><img src="https://indexed.vc/api/badge/company/20-20-onsite" alt="20/20 Onsite on Indexed.vc" width="260" height="76" /></a>